- OncoTree
- PTH
Loading cancer entity…
Loading cancer entity…
Clinical trials
15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (0)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07843901 | Lenvatinib in Patients With Advanced Parathyroid Carcinoma(ALPS) | not yet recruiting | Phase 2 | 18 | Yonsei UniversityOTHER | 0 | Sep 28, 2026 | clinicaltrials |
| NCT04969926 | Natural History Study of Parathyroid Disorders | recruiting | — | 3,000 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Sep 17, 2026 | clinicaltrials |
| NCT07444723 | Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors | recruiting | Phase 2 / Phase 3 | 193 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Jun 2, 2026 | clinicaltrials |
| NCT06638931 | Agnostic Therapy in Rare Solid Tumors(ANTARES) | recruiting | Phase 2 | 28 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT07475780 | Radiofrequency Ablation For Recurrent Parathyroid Carcinoma | recruiting | N/A | 20 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT05022641 | Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy | completed | N/A | 160 | University of MichiganOTHER | 1 | Aug 27, 2025 | clinicaltrials |
| NCT06852144 | PET-TC in Thyroid Evaluation(PEPATI-MN-2024) | enrolling by invitation | — | 418 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT04299425 | Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy(NIRAF) | completed | N/A | 160 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | May 13, 2024 | clinicaltrials |
| NCT05789680 | European Multicentric Study on Parathyroid Carcinoma(EMS-PC) | unknown | — | 17 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 29, 2023 | clinicaltrials |
| NCT03280264 | Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism | completed | Phase 3 | 18 | Kyowa Kirin Co., Ltd.INDUSTRY | 1 | May 27, 2021 | clinicaltrials |
| NCT03046524 | Parathyroid Cancer Versus Atypical Parathyroid Neoplasm; Investigating Their Clinical Characteristics and Biological Behavior | completed | — | 100 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 7, 2018 | clinicaltrials |
| NCT01460030 | An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism | completed | Phase 3 | — | Kyowa Kirin Co., Ltd.INDUSTRY | 1 | Mar 3, 2017 | clinicaltrials |
| NCT00580320 | Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma | completed | Phase 1 | 17 | Virginia Commonwealth UniversityOTHER | 1 | Aug 18, 2016 | clinicaltrials |
| NCT00004074 | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu | completed | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00068497 | Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer | completed | N/A | 40 | National Cancer Institute (NCI)NIH | 1 | Jan 14, 2013 | clinicaltrials |
Data updated 24 hours agoSource updated Sep 28, 2026source: clinicaltrials